Cardiovascular diseases in Brazil: Premature mortality, risk factors and priorities for action. Comments on the preliminary results from the Brazilian National Health Survey (PNS), 2013;Doenças cardiovasculares no Brasil: Mortalidade prematura, fatores de risco e prioridades de ação. Comentários sobre os resultados preliminares da Pesquisa Nacional de Saúde (PNS), 2013

Sao Paulo Medical Journal

Volumn 133, Issue 2, 2015, Pages 69-72

  Lotufo, Paulo Andrade ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ANGIOPLASTY; BRAZIL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; EDITORIAL; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; INCIDENCE; MALE; PREMATURE MORTALITY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK MANAGEMENT; CARDIOVASCULAR DISEASES; COMPLICATION; CORONARY DISEASE; EPIDEMIOLOGY; HEALTH CARE PLANNING; MORBIDITY; MORTALITY; MYOCARDIAL INFARCTION; ORGANIZATION AND MANAGEMENT; RISK FACTOR; SMOKING;

BRAZIL; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DYSLIPIDEMIAS; HEALTH PRIORITIES; HEALTH SURVEYS; HUMANS; INCIDENCE; MORBIDITY; MORTALITY, PREMATURE; MYOCARDIAL INFARCTION; PREVALENCE; RISK FACTORS; SMOKING;

EID: 84929678146     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-3180.2015.13320018     Document Type: Editorial

References (25)

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71.
2. Lotufo PA. Why has the rise in obesity not reversed the decline in cardiovascular mortality? Cardiometabolic death rate trends in Brazil (1980-2011). Sao Paulo Med J. 2015;133(1):1-3.
3. Lotufo PA, Goulart AC, Fernandes TG, Benseñor IM. A reappraisal of stroke mortality trends in Brazil (1979-2009). Int J Stroke. 2013;8(3):155-63.
4. World Health Organization. Hypertensive diseases. In: World Health Organization. International Classification of Diseases (ICD). 10th ed. Available from: http://apps.who.int/classifications/icd10/ browse/2015/en#/I10-I15. Accessed in 2015 (Mar 10).
5. World Health Organization. Ischaemic heart diseases. In: World Health Organization. International Classification of Diseases (ICD). 10th ed. Available from: http://apps.who.int/classifications/icd10/ browse/2015/en#/I20-I25. Accessed in 2015 (Mar 10).
6. World Health Organization. Cerebrovascular diseases. In: World Health Organization. International Classification of Diseases (ICD). 10th ed. Available from: http://apps.who.int/classifications/icd10/ browse/2015/en#/I60-I69. Accessed in 2015 .
7. McGovern PG, Jacobs DR, Jr, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation. 2001;104(1):19-24.
8. Goulart AC, Santos IS, Sitnik D, et al. Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study). Clinics (Sao Paulo). 2013;68(3):431-4.
9. Nicolau JC, Franken M, Lotufo PA, et al. Utilização de terapêuticas comprovadamente úteis no tratamento da coronariopatia aguda: comparação entre diferentes regiões brasileiras. Análise do Registro Brasileiro de Síndromes Coronarianas Agudas (BRACE-Brazilian Registry on Acute Coronary Syndromes) [Use of demonstrably effective therapies in the treatment of acute coronary syndromes: comparison between different Brazilian regions. Analysis of the Brazilian Registry on Acute Coronary Syndromes (BRACE)]. Arq Bras Cardiol. 2012;98(4):282-9.
10. Piva e Mattos LA, Berwanger O, Santos ES, et al. Desfechos clínicos aos 30 dias do registro brasileiro das síndromes coronárias agudas (ACCEPT) [Clinical outcomes at 30 days in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT)]. Arq Bras Cardiol. 2013;100(1):6-13.
11. Brasil. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde 2013. Percepção do estado de saúde, estilos de vida e doenças crônicas. Brasil, Grandes Regiões e Unidades da Federação. Available from: http://www.ibge.gov.br/home/estatistica/populacao/ pns/2013/default.shtm. Accessed in 2015 (Mar 10).
12. Schmidt MI, Hoffmann JF, Diniz MFS, et al. High prevalence of diabetes and intermediate hyperglycemia – The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetology & Metabolic Syndrome. 2014;6:123. Available from: http://www.dmsjournal.com/content/ pdf/1758-5996-6-123.pdf. Accessed in 2015 (Mar 10).
13. Oliveira JE, Milech A, Franco LJ. The prevalence of diabetes in Rio de Janeiro, Brazil. The Cooperative Group for the Study of Diabetes Prevalence in Rio de Janeiro. Diabetes Care. 1996;19(6):663-6.
14. Torquato MT, Montenegro Júnior RM, Viana LA, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30-69 years in Ribeirão Preto (São Paulo), Brazil. Sao Paulo Med J. 2003;121(6):224-30.
15. Rasella D, Harhay MO, Pamponet ML, Aquino R, Barreto ML. Impact of primary health care on mortality from heart and cerebrovascular diseases in Brazil: a nationwide analysis of longitudinal data. BMJ. 2014;349:g4014.
16. Brasil. Ministério da Saúde. Plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis (DCNT) no Brasil 2011-2022. Brasília: Ministério da Saúde; 2011. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/plano_acoes_enfrent_ dcnt_2011.pdf. Accessed in 2015 (Mar 10).
17. Lotufo PA, Pereira AC, Vasconcellos PS, et al. Resistant hypertension: risk factors, subclinical atherosclerosis, and comorbidities among adults-the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J Clin Hypertens (Greenwich). 2015;17(1):74-80.
18. Lotufo PA, Benseñor IM. Stroke mortality in Brazil: one example of delayed epidemiological cardiovascular transition. Int J Stroke. 2009;4(1):40-1.
19. Lotufo PA, Benseñor IJ. Raça e mortalidade cerebrovascular no Brasil [Race and stroke mortality in Brazil]. Rev Saude Publica. 2013;47(6):1201-4.
20. Rego RA, Berardo FAN, Rodrigues SSF, et al. Fatores de risco para doenças crônicas não-transmissíveis: inquérito domiciliar no Município de São Paulo, SP (Brasil). Metodologia e resultados preliminares [Risk factors for non-communicable chronic diseases: a domiciliary survey in the Municipality of São Paulo, (Brazil). Methodology and preliminary results]. Rev Saude Publica. 1990;24(4):277-85.
21. Mottillo S, Filion KB, Bélisle P, et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30(6):718-30.
22. Eisenberg MJ, Filion KB, Yavin D, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ. 2008;179(2):135-44.
23. Dawber TR, Kannel WB, Revotskie N, et al. Some factors associated with the development of coronary heart disease: six years’ follow-up experience in the Framingham study. Am J Public Health Nations Health. 1959;49:1349-56.
24. McConnachie A, Walker A, Robertson M, et al. Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study. Eur Heart J. 2014;35(5):290-8.
25. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-934.